Ren 2006.
Methods | Eight‐week, (likely) randomised study. |
Participants | In‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 54 participants. Sertraline: 48 participants. Citalopram dose range: 20‐60 mg/day. Sertraline dose range: 50‐150 mg/day. |
Outcomes | Change in Hamilton Depression Rating Scale 24 Item (HDRS‐24) score from baseline to endpoint, number of patients who responded to treatment, number of patients who remitted. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |